Illustrative image (Photo: VNA)Speaking at the Government’sregular press meeting on April 4, Deputy Minister of Health Do Xuan Tuyen said thethree vaccine candidates are Nano Covax, Covivac, and ARCT-154.
Nano Covax has reached the thirdphase’s mid-term review. Its producer, Nanogen Pharmaceutical BiotechnologyJSC, is supplementing data to its dossier at the request of the advisorycouncil, which will convene more meetings on this candidate’s eligibility.
Covivac, developed by theInstitute of Vaccines and Medical Biologicals, is undergoing second-phase assessmentand prepared to enter third-phase clinical trials.
Meanwhile, ARCT-154, the first to beproduced using the mRNA technology in Vietnam, of the VinBioCare BiotechnologyJSC already underwent mid-term review of clinical trials on the first 1,000volunteers and is now in Phase 3b.
As these are human vaccines,they must ensure high safety and need full research and assessment, Tuyen noted.
The Government’s regular press meeting on April 4 (Photo: VNA)On April 3, the MoH hadmeetings with the Australian Embassy and Pfizer, both of which agreed to delivervaccines to Vietnam as soon as possible. The authorised vaccines for childrenconsist of Pfizer and Moderna.
The Australian Embassyexpected that if procedures are completed quickly, the first batch of Modernavaccine can be handed over as early as April 10, according to the official.
He added a recent survey bythe MoH’s Health Strategy and Policy Institute shows that the rate of parentsagreeing on the vaccination for children aged 5 - 11 varies, from 60 to 80 percent. Giventhis, the ministry has devised a communications plan and organised training sothat child vaccination can be carried out as soon as vaccines are available./.
VNA
